EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Association of Baseline Depression and Anxiety with Longitudinal Health Outcomes in Parkinson's Disease

Yiwen Shi iD, Roseanne Dobkin, Daniel Weintraub iD, Hyunkeun R Cho, Chelsea Caspell-Garcia, Meredith Bock iD, Ethan Brown iD, Dag Aarsland, Nabila Dahodwala

Movement Disorders Clinical Practice · 2024-09 · 11 (9) · 1103-1112

DOI: 10.1002/mdc3.14145 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Movement Disorders Clinical Practice, online erschienen am 22.06.2024. Verfasst von Yiwen Shi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA. Hauptthemen laut MEDLINE: Parkinson Disease, Anxiety, Depression. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Anxiety and depression are common non‐motor symptoms in Parkinson's disease (PD) but remain under‐recognized and under‐treated.

Objectives

To evaluate functional outcomes associated with baseline anxiety or depression and effects related to the initiation of new psychiatric treatment.

Methods

We analyzed 7 years of data from patients with de novo PD enrolled in the Parkinson's Progression Markers Initiative. Longitudinal regression models evaluated the association between baseline anxiety and depression with Schwab and England (SE) and MDS‐UPDRS total scores over time. Cox proportional hazard models assessed effects of baseline anxiety and depression on time to initiation of dopaminergic therapy. Piecewise linear regression models examined the association of treatment initiation for anxiety and depression with SE and MDS‐UPDRS.

Results

490 participants with baseline depression and anxiety data were included. Anxiety and depression were associated with lower SE (anxiety: β = −1.31, P = 0.038, depression: β = −1.96, P = 0.012, co‐morbid: β = −2.70, P = 0.003) and higher MDS‐UPDRS scores (anxiety: β = 5.37, P < 0.001, depression: β = 9.17, P < 0.001, co‐morbid: β = 10.50, P < 0.001) longitudinally. Anxiety was associated with faster time to dopamine replacement therapy initiation (HR 1.30, 95% CI 1.03–1.66, P = 0.03). 16 participants with anxiety initiated treatment for anxiety, which was associated with subsequent lower levodopa daily dose (slope change = −218.49, P = 0.018). 10 participants with depression initiated treatment of depression, which was associated with reduced MDS‐UPDRS total scores (slope change = −8.3, P < 0.001) and higher SE scores (slope change = 5.99, P = 0.004).

Conclusions

Anxiety and depression at PD onset are associated with multiple negative longitudinal trajectories. However, preliminary findings suggest that anxiety and depression treatment may be linked with improved motor and non‐motor outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinson DiseaseAnxietyDepressionHumansMaleFemaleAgedMiddle AgedLongitudinal StudiesSeverity of Illness IndexDisease ProgressionTreatment Outcome

Stichwörter der Autor:innen

PPMIParkinson's diseaseanxiety and depressionneuropsychiatric symptoms

Autor:innen und Institutionen

  • Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Department of Psychiatry, Rutgers University, Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA.
  • Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Department of Veterans Affairs, Parkinson's Disease Research, Education and Clinical Center, Philadelphia, Pennsylvania, USA.
  • Department of Biostatistics, College of Public Health, University of Iowa, Iowa City, Iowa, USA.
  • Department of Neurology, The San Francisco Veterans Affairs Medical Center, University of California, San Francisco, San Francisco, California, USA.

ORCID-Profile: Yiwen Shi, Daniel Weintraub, Meredith Bock, Ethan Brown

Zitieren

APA

Shi, Y., Dobkin, R., Weintraub, D., Cho, H. R., Caspell-Garcia, C., Bock, M., Brown, E., Aarsland, D., & Dahodwala, N. (2024). Association of Baseline Depression and Anxiety with Longitudinal Health Outcomes in Parkinson's Disease. Movement Disorders Clinical Practice, 11(9), 1103-1112. https://doi.org/10.1002/mdc3.14145

Vancouver

Shi Y, Dobkin R, Weintraub D, Cho HR, Caspell-Garcia C, Bock M, et al. Association of Baseline Depression and Anxiety with Longitudinal Health Outcomes in Parkinson's Disease. Movement Disorders Clinical Practice. 2024;11(9):1103-1112. doi:10.1002/mdc3.14145

BibTeX
@article{Shi2024,
  author = {Shi, Yiwen and Dobkin, Roseanne and Weintraub, Daniel and Cho, Hyunkeun R and Caspell-Garcia, Chelsea and Bock, Meredith and Brown, Ethan and Aarsland, Dag and Dahodwala, Nabila},
  title = {Association of Baseline Depression and Anxiety with Longitudinal Health Outcomes in Parkinson's Disease},
  journal = {Movement Disorders Clinical Practice},
  year = {2024},
  volume = {11},
  number = {9},
  pages = {1103--1112},
  doi = {10.1002/mdc3.14145}
}
Kostenlos starten →